Depression that resists standard medication is a serious condition that affects many adults; it can leave them without adequate relief despite multiple treatment attempts. Spravato is a nasal spray administered in a certified clinical setting, offering an alternative path forward for those who have not responded to conventional antidepressants. Understanding how Spravato treatment works and who it is designed for can help patients approach the conversation with a mental health provider with clarity.
What Is Spravato Treatment?
Spravato is the brand name for esketamine, and it is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treatment-resistant depression. Unlike most antidepressants, which come as pills taken at home, Spravato is delivered as a nasal spray in a clinical setting. A patient self-administers the spray under the direct observation of trained staff.
This supervised model exists because the medication can produce short-term effects that require monitoring. Spravato is typically not used on its own; it functions as one part of a wider treatment plan that may include an oral antidepressant, therapy, and ongoing medical support. Because of these requirements, Spravato treatment is available only through certified healthcare settings.
What Is It Used For?
Spravato is prescribed for adults with specific depression-related conditions, and providers evaluate each person before recommending it. Treatment-resistant depression is a term that describes depression that has not improved after a person has tried at least two different antidepressant medications at adequate doses. In select cases, a provider may prescribe Spravato for adults experiencing severe depressive episodes accompanied by suicidal ideation.
Traditional antidepressants usually target brain chemicals such as serotonin, dopamine, or norepinephrine. Spravato takes a different route. Its active ingredient, esketamine, acts on a chemical messenger called glutamate. Glutamate plays a role in how brain cells communicate; it can also influence how mood, thinking, and emotional regulation are managed. By working through this pathway, Spravato addresses depression from a mechanism separate from standard pills.
What Should You Expect?
Spravato treatment follows a structured, in-office routine. You will take the nasal spray while seated in a monitored space. After administration, staff observe you for a set period of time. The medication can cause temporary drowsiness, dizziness, or a sense of detachment, so patients are advised not to drive after a session.
Treatment Schedule
A typical plan begins with an initial phase of more frequent sessions, followed by a maintenance phase with visits spaced further apart. The exact cadence depends on how a person responds, and it is determined based on the provider’s clinical judgment. Regular reassessment guides any adjustments.
Response Timelines
Individual results vary. Some people notice shifts in mood or energy within hours or days, and others may take longer. Certain factors, such as the severity of symptoms, overall health, and the presence of other therapies, all influence the pace of change. A provider tracks progress throughout the course of treatment.
Seek Professional Mental Health Care
Spravato represents one approach among several tools available in modern psychiatric care. If depressive symptoms are affecting your daily life, reaching out to a mental health professional is a practical first step. A provider can review your medical history, and they will design a plan matched to your needs.